Involvement of protoporphyrin IX accumulation in the pathogenesis of isoniazid/rifampicin-induced liver injury: the prevention of curcumin

References

• Adhvaryu MR, Reddy N, Vakharia BC. (2008). Prevention of hepatotoxicity due to anti tuberculosis treatment: a novel integrative approach. World J Gastroenterol 14:4753–62
   PubMed Web of Science ®Google Scholar
• Alsultan A, Peloquin CA. (2014). Therapeutic drug monitoring in the treatment of tuberculosis: an update. Drugs 74:839–54
   PubMed Web of Science ®Google Scholar
• Amouzadeh HR, Pohl LR. (1995). Processing of endoplasmic reticulum luminal antigens associated with halothane hepatitis in rat hepatocytes. Hepatology 22:936–43
   PubMed Web of Science ®Google Scholar
• Anstey AV, Hift RJ. (2007). Liver disease in erythropoietic protoporphyria: insights and implications for management. Gut 56:1009–18
   PubMed Web of Science ®Google Scholar
• Campbell MR, Karaca M, Adamski KN, et al. (2013). Novel hematopoietic target genes in the NRF2-mediated transcriptional pathway. Oxid Med Cell Longev 2013:120305
   PubMed Web of Science ®Google Scholar
• Casanova-Gonzalez MJ, Trapero-Marugan M, Jones EA, Moreno-Otero R. (2010). Liver disease and erythropoietic protoporphyria: a concise review. World J Gastroenterol 16:4526–31
   PubMed Web of Science ®Google Scholar
• Chen R, Wang J, Zhang Y, et al. (2015). Key factors of susceptibility to anti-tuberculosis drug-induced hepatotoxicity. Arch Toxicol 89:883–97
   PubMed Web of Science ®Google Scholar
• Chowdhury A, Santra A, Bhattacharjee K, et al. (2006). Mitochondrial oxidative stress and permeability transition in Isoniazid and Rifampicin induced liver injury in mice. J Hepatol 45:117–26
   PubMed Web of Science ®Google Scholar
• Enriquez-Cortina C, Almonte-Becerril M, Clavijo-Cornejo D, et al. (2013). Hepatocyte growth factor protects against isoniazid/rifampicin-induced oxidative liver damage. Toxicol Sci 135:26–36
   PubMed Web of Science ®Google Scholar
• Fickert P, Stoger U, Fuchsbichler A, et al. (2007). A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol 171:525–36
   PubMed Web of Science ®Google Scholar
• Fraser DJ, Zumsteg A, Meyer UA. (2003). Nuclear receptors constitutive androstane receptor and pregnane X receptor activate a drug-responsive enhancer of the murine 5-aminolevulinic acid synthase gene. J Biol Chem 278:39392–401
   PubMed Web of Science ®Google Scholar
• Guo YX, Xu XF, Zhang QZ, et al. (2015). The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid/rifampicin-induced hepatotoxicity. Toxicol Mech Methods 25:382–7
   PubMed Web of Science ®Google Scholar
• Gupta V, Liu S, Ando H, et al. (2013). Salicylic acid induces mitochondrial injury by inhibiting ferrochelatase heme biosynthesis activity. Mol Pharmacol 84:824–33
   PubMed Web of Science ®Google Scholar
• Holme SA, Anstey AV, Finlay AY, et al. (2006). Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life. Br J Dermatol 155:574–81
   PubMed Web of Science ®Google Scholar
• Ji L, Sheng Y, Zheng Z, et al. (2015). The involvement of p62–Keap1–Nrf2 antioxidative signaling pathway and JNK in the protection of natural flavonoid quercetin against hepatotoxicity. Free Radical Bio Med 85:12–23
   PubMed Web of Science ®Google Scholar
• Ji ZY, Zhao LQ, Yang GR, et al. (2006). Effects of differentiation of human esophageal cancer cells on 5-aminolevulinic acid-induced endogenous protopophyrin IX production and photodynamic therapy. World Chinese J. Digestol 14:6–11
   Google Scholar
• Jigorel E, Le Vee M, Boursier-Neyret C, et al. (2006). Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab Dispos 34:1756–63
   PubMed Web of Science ®Google Scholar
• Kemmner W, Wan K, Ruttinger S, et al. (2008). Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer. Faseb J 22:500–9
   PubMed Web of Science ®Google Scholar
• Kobuchi H, Moriya K, Ogino T, et al. (2012). Mitochondrial localization of ABC transporter ABCG2 and its function in 5-aminolevulinic acid-mediated protoporphyrin IX accumulation. PLoS One 7:e50082
   PubMed Web of Science ®Google Scholar
• Krishnamurthy P, Schuetz JD. (2006). Role of ABCG2/BCRP in biology and medicine. Annu Rev Pharmacol Toxicol 46:381–410
   PubMed Web of Science ®Google Scholar
• Lecha M, Puy H, Deybach JC. (2009). Erythropoietic protoporphyria. Orphanet J Rare Dis 4:19
   PubMed Web of Science ®Google Scholar
• Lehmann JM, McKee DD, Watson MA, et al. (1998). The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102:1016–23
   PubMed Web of Science ®Google Scholar
• Lemmen J, Tozakidis IE, Galla HJ. (2013). Pregnane X receptor upregulates ABC-transporter Abcg2 and Abcb1 at the blood–brain barrier. Brain Res 1491:1–13
   PubMed Web of Science ®Google Scholar
• Li F, Lu J, Cheng J, et al. (2013). Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy. Nat Med 19:418–20
   PubMed Web of Science ®Google Scholar
• Li Q, Wang J, Wang X, Zeng J. (2007). Establishment and identification of insulin-resistant L02 cell model induced with insulin. Mod Prev Med 34:4233–5
   Google Scholar
• Lin YH, Chang HM, Chang FP, et al. (2013). Protoporphyrin IX accumulation disrupts mitochondrial dynamics and function in ABCG2-deficient hepatocytes. FEBS Lett 587:3202–9
   PubMed Web of Science ®Google Scholar
• Liu PI, Lim JY. (1987). Sideroblastic anemia. JAMA 257:2814
   PubMed Web of Science ®Google Scholar
• Lyoumi S, Abitbol M, Rainteau D, et al. (2011). Protoporphyrin retention in hepatocytes and Kupffer cells prevents sclerosing cholangitis in erythropoietic protoporphyria mouse model. Gastroenterology 141:1509–19. 1511–19
   PubMed Web of Science ®Google Scholar
• Magesh S, Chen Y, Hu L. (2012). Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents. Med Res Rev 32:687–726
   PubMed Web of Science ®Google Scholar
• Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. (2006). Multiple biological activities of curcumin: a short review. Life Sci 78:2081–7
   PubMed Web of Science ®Google Scholar
• Maitra D, Elenbaas JS, Whitesall SE, et al. (2015). Ambient light promotes selective subcellular proteotoxicity after endogenous and exogenous porphyrinogenic stress. J Biol Chem 290:23711–24
   PubMed Web of Science ®Google Scholar
• McGill MR, Jaeschke H. (2013). Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res 30:2174–87
   PubMed Web of Science ®Google Scholar
• Metushi IG, Uetrecht J, Phillips E. (2016). Mechanism of isoniazid-induced hepatotoxicity: then and now. Brit J Clin Pharmacol 269:31041–6
   Google Scholar
• Pastorino JG, Simbula G, Gilfor E, et al. (1994). Protoporphyrin IX, an endogenous ligand of the peripheral benzodiazepine receptor, potentiates induction of the mitochondrial permeability transition and the killing of cultured hepatocytes by rotenone. J Biol Chem 269:31041–6
   PubMed Web of Science ®Google Scholar
• Piso RJ, Kriz K, Desax MC. (2011). Severe isoniazid related sideroblastic anemia. Hematol Rep 3:e2
   PubMedGoogle Scholar
• Puy H, Gouya L, Deybach JC. (2010). Porphyrias. Lancet 375:924–37
   PubMed Web of Science ®Google Scholar
• Ramappa V, Aithal GP. (2013). Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management. J Clin Exp Hepatol 3:37–49
   PubMedGoogle Scholar
• Ratajewski M, Grzelak I, Wisniewska K, et al. (2014). Screening of a chemical library reveals novel PXR-activating pharmacologic compounds. Toxicol Lett 232:193–202
   PubMed Web of Science ®Google Scholar
• Rivera-Espinoza Y, Muriel P. (2009). Pharmacological actions of curcumin in liver diseases or damage. Liver Int 29:1457–66
   PubMed Web of Science ®Google Scholar
• Rüfenacht UB, Gouya L, Schneider-Yin X, et al. (1998). Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria. Am J Hum Genet 62:1341–52
   PubMed Web of Science ®Google Scholar
• Sachar M, Anderson KE, Ma X. (2016). Protoporphyrin IX: the Good, the Bad, and the Ugly. J Pharmacol Exp Ther 356:267–75
   PubMed Web of Science ®Google Scholar
• Shapiro H, Ashkenazi M, Weizman N, et al. (2006). Curcumin ameliorates acute thioacetamide-induced hepatotoxicity. J Gastroenterol Hepatol 21:358–66
   PubMed Web of Science ®Google Scholar
• Shih T, Young T, Lee H, et al. (2013). Protective effects of kaempferol on isoniazid- and rifampicin-induced hepatotoxicity. AAPS J 15:753–62
   PubMed Web of Science ®Google Scholar
• Singh M, Sasi P, Gupta VH, et al. (2012). Protective effect of curcumin, silymarin and N-acetylcysteine on antitubercular drug-induced hepatotoxicity assessed in an in vitro model. Hum Exp Toxicol 31:788–97
   PubMed Web of Science ®Google Scholar
• Stieger B, Fattinger K, Madon J, et al. (2000). Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology 118:422–30
   PubMed Web of Science ®Google Scholar
• Swift B, Pfeifer ND, Brouwer KL. (2010). Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metab Rev 42:446–71
   PubMed Web of Science ®Google Scholar
• Tamura M, Kondo M, Horio M, et al. (2012). Genetic polymorphisms of the adenosine triphosphate-binding cassette transporters (ABCG2, ABCB1) and gefitinib toxicity. Nagoya J Med Sci 74:133–40
   PubMed Web of Science ®Google Scholar
• Tu CT, Yao QY, Xu BL, et al. (2012). Protective effects of curcumin against hepatic fibrosis induced by carbon tetrachloride: modulation of high-mobility group box 1, Toll-like receptor 4 and 2 expression. Food Chem Toxicol 50:3343–51
   PubMed Web of Science ®Google Scholar
• Vera-Ramirez L, Perez-Lopez P, Varela-Lopez A, et al. (2013). Curcumin and liver disease. Biofactors 39:88–100
   PubMed Web of Science ®Google Scholar
• Wang W, He Y, Lin P, et al. (2014). In vitro effects of active components of Polygonum Multiflorum Radix on enzymes involved in the lipid metabolism. J Ethnopharmacol 153:763–70
   PubMed Web of Science ®Google Scholar
• Yang K, Pfeifer ND, Kock K, Brouwer KL. (2015). Species differences in hepatobiliary disposition of taurocholic acid in human and rat sandwich-cultured hepatocytes: implications for drug-induced liver injury. J Pharmacol Exp Ther 353:415–23
   PubMed Web of Science ®Google Scholar
• Yao Q, Lin Y, Li X, et al. (2013). Curcumin ameliorates intrahepatic angiogenesis and capillarization of the sinusoids in carbon tetrachloride-induced rat liver fibrosis. Toxicol Lett 222:72–82
   PubMed Web of Science ®Google Scholar
• Yeh HJ, Chu TH, Shen TW. (1980). Ultrastructure of continuously cultured adult human liver cell. Acta Biol Expert Sin 13:361–9
   Google Scholar
• Yoshimoto S, Takeuchi M, Tada A. (1992). Secondary sideroblastic anemia caused by long term administration of anti-tuberculous agents including isoniazid. Rinsho Ketsueki 33:986–90
   PubMedGoogle Scholar